Cargando…

Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators

BACKGROUND: The European Society of Breast Cancer Specialists (EUSOMA) has defined quality indicators for breast cancer (BC). The aim of this study was to describe the preoperative clinical pathway of breast cancer patients and evaluate the determinants of compliance with EUSOMA quality indicators i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Héquet, Delphine, Huchon, Cyrille, Baffert, Sandrine, Alran, Séverine, Reyal, Fabien, Nguyen, Thuy, Combes, Alix, Trichot, Caroline, Alves, Karine, Berseneff, Hélène, Rouzier, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520093/ https://www.ncbi.nlm.nih.gov/pubmed/28441385 http://dx.doi.org/10.1038/bjc.2017.114

Ejemplares similares

The patient-breast cancer care pathway: how could it be optimized?
por: Baffert, Sandrine, et al.
Publicado: (2015)

Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study
por: Héquet, Delphine, et al.
Publicado: (2019)

Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study
por: Arfi, Alexandra, et al.
Publicado: (2018)

Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study
por: Cariou, Amélie, et al.
Publicado: (2018)

Preoperative CT or PET/CT to Assess Pelvic and Para-Aortic Lymph Node Status in Epithelial Ovarian Cancer? A Systematic Review and Meta-Analysis
por: Mimoun, Camille, et al.
Publicado: (2021)

Determinants of geographic inequalities in HPV vaccination in the most populated region of France
por: Héquet, Delphine, et al.
Publicado: (2017)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy
por: Héquet, Delphine, et al.
Publicado: (2013)

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(®) Test in the management of early-stage breast cancers
por: Hequet, Delphine, et al.
Publicado: (2017)

The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
por: van Dam, Peter, et al.
Publicado: (2022)

Comment on: “Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study”
por: Ratosa, Ivica, et al.
Publicado: (2020)

Multidisciplinary team meeting as a highly recommended EUSOMA criteria evaluating the quality of breast cancer management between centers
por: Souadka, Amine, et al.
Publicado: (2021)

Troubles anxieux et depressifs des patientes pendant la pandémie Covid-19
por: Dahan, Meryl, et al.
Publicado: (2020)

Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review
por: Dahan, Meryl, et al.
Publicado: (2021)

Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France
por: Eliès, Antoine, et al.
Publicado: (2022)

Impact de la pandémie de COVID-19 sur la prise en charge du cancer du sein : retour d’expérience d’un centre de lutte contre le cancer
por: Tran, Mélanie, et al.
Publicado: (2022)

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
por: Raymond, Eric, et al.
Publicado: (2020)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
por: Bidard, François-Clément, et al.
Publicado: (2013)

Non-Invasive Tools for the Diagnosis of Potentially Life-Threatening Gynaecological Emergencies: A Systematic Review
por: Polena, Viola, et al.
Publicado: (2015)

Reply to Ivica Ratosa et al. Comment on: “Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study”
por: Pons-Tostivint, E., et al.
Publicado: (2020)

Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application
por: Laas, Enora, et al.
Publicado: (2016)

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
por: Curtit, Elsa, et al.
Publicado: (2023)

Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care during COVID-19 outbreak in North-Eastern Italy. When the going gets tough, the tough gets going!
por: Giacometti, C., et al.
Publicado: (2020)

Cognitive status predicts preoperative instruction compliance
por: Mano, Yasuko, et al.
Publicado: (2023)

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery
por: Gosset, Marie, et al.
Publicado: (2016)

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population
por: Rossi, Lea, et al.
Publicado: (2015)

Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein
por: Héquet, Delphine, et al.
Publicado: (2020)

Skin Lesions after Prophylactic Mastectomy and Immediate Reconstruction
por: Baulies, Sonia, et al.
Publicado: (2014)

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
por: Labrosse, Julie, et al.
Publicado: (2020)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
por: Mahiou, Katia, et al.
Publicado: (2023)

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in real‐life settings
por: Hequet, D., et al.
Publicado: (2023)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy, Anne-Sophie, et al.
Publicado: (2018)

Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review
por: Conti, Benoit, et al.
Publicado: (2022)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy-Petit, Anne-Sophie, et al.
Publicado: (2016)

Does a Preoperative Educational Class Increase Patient Compliance
por: Kim, Kelvin, et al.
Publicado: (2015)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

Computing Molecular Signatures as Optima of a Bi-Objective Function: Method and Application to Prediction in Oncogenomics
por: Gardeux, Vincent, et al.
Publicado: (2015)

Is a Self-Assessed Questionnaire Useful for the Diagnosis of Ectopic Pregnancy in Hospitalized Patients?
por: Mimoun, Camille, et al.
Publicado: (2016)

From prospective clinical trial to reducing social inequalities in health: The DESSEIN trial, concept and design of a multidisciplinary study in precarious patients with breast cancer
por: Ngô, Charlotte, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iuqnlo41cjf0502ssp2not7bei